Norwalk Leslie V 4

What Happened
Leslie V. Norwalk, a director of Globus Medical, was granted a derivative equity award of 15,000 shares on January 21, 2026. The grant was reported on a Form 4 filed January 23, 2026. The award was recorded at $0.00 per share in the filing and is described in a footnote as options that will vest on January 1, 2027.

Key Details

• Transaction date: 2026-01-21; Form 4 filed: 2026-01-23 (timely filing).
• Transaction type: Award/Grant (derivative option grant), amount: 15,000 shares; reported acquisition price: $0.00.
• Vesting: The options were granted Jan 21, 2026 and will vest on Jan 1, 2027 (footnote F1).
• Shares owned after transaction: Not specified in this filing.
• No sale or immediate disposition reported (not a cashless exercise or sale).

Context
This is an equity compensation grant to a company director, not an open-market purchase or sale. Such awards are common for executive and director compensation and do not by themselves indicate buying or selling sentiment. Because these are options that vest in the future, they provide an incentive for continued service and alignment with long-term shareholder interests.